| Revenue growth | 19.62% YoY growth in Q1 FY27. |
|---|---|
| Margins | EBITDA margin at 25.5% (calc); PAT margin at 9.1% (calc). |
| Demand visibility | Strong; 3.19 million tests performed in Q1 alone. |
| Management confidence | High; citing strategic refinement and rapid network scaling. |
Growth
Q1 FY27 revenue reached ₹82.26 Cr (up 19.62% YoY) and PAT hit ₹7.50 Cr (up 29.51% YoY).
Outlook
Targeting 1,000+ franchises by FY27; launching 2 PET-CT centres and Genome Lab; expanding pan-India network via CMC model.
Risks
Realignment through pharmacy business exit; competitive landscape in Tier 2/3 markets; high reliance on North India.
Investor Presentation filed with NSE, NSE: CHANDAN. Summary written with AI assistance from the document.
Chandan Healthcare Ltd: key numbers
- Share price
- ₹238.00
- Market cap
- ₹611.7 Cr
- Revenue (annual)
- ₹276.4 Cr
- Net profit (annual)
- ₹27.06 Cr
- P/E (TTM)
- 22.6×Sector 54.5×
- Promoter holding
- 47.20%-2.41% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Chandan Healthcare Ltd
All →Chandan Healthcare Other Announcement
Chandan Healthcare filed Crisil's monitoring report on warrant issue proceeds for the quarter ended September 30, 2026. Utilisation matched the stated objects with no deviation or delay.
Chandan Healthcare Annual General Meeting
Chandan Healthcare calls an EGM on 20 November 2026 to approve related party transactions, including director guarantees. E-voting runs 17 to 19 November 2026.
Chandan Healthcare Results Update
Chandan Healthcare's Q2 FY2027 revenue from diagnostics grew 46.66% YoY to Rs. 56.38 Crore, while its franchise network expanded to 685 locations.
- franchise expansion
- 410.0 franchises
Chandan Healthcare Debt & Borrowing: ₹5.22 Cr
Chandan Healthcare Limited secured a ₹5.22 Crore medical equipment loan from ICICI Bank for purchasing a 128-slice CT scanner.
- Value
- ₹5.22 Cr
- Execution
- 60 months
Chandan Healthcare Management Change
Mr. Vinod Jain has resigned from his position as Independent Director of Chandan Healthcare Limited, effective October 5, 2026, due to other professional commitments.
Chandan Healthcare Annual General Meeting
Chandan Healthcare Limited held its 23rd Annual General Meeting on September 30, 2026. The meeting covered routine business, including financial adoption and board appointments.